5% de descuento en todos los libros solicitados por la web

Therapy of Nephrology and Hypertension

145.6
138.32
The latest edition of this companion to Brenner and Rector's The Kidney focuses on the management and treatment of renal disease and hypertension, and the present consensus regimens. An international team of over 100 experts emphasise the specifics of treatment, from an evidence-based perspective , while presenting field-tested advice on the best therapeutics available.

A concise and highly readable text, the book is divided into three sections

An introduction covering clinical features, pathology and pathophysiology - these are discussed only briefly in order to launch a detailed discussion of therapy
* A section with rationales for therapy - each chapter here provides summaries and critiques of clinical trials that offer clear, balanced guidance on how to approach and implement treatment
A section discussing specific treatment recommendations , which are made by the editorial team wherever consensus is not available

What's New

A wealth of international new contributors have been added, all leading authorities on the subject, in order to achieve a truly global perspective on therapy.
Short, self contained chapters that provide focused assessment of the subject at hand
A extensive yet focused reference list that includes landmark articles
An abundance of illustrations, tables and diagnostic algorithms that aid the decision-making process

Contents

Part I: General Principles of Clinical Trials
1. Clinical Trials in Nephrology and Hypertension

Part II: Acute Renal Failure (ARF)
2. Management of ARF
3. Use of Crystalloids and Colloids
4. Dopamine Therapy
5. Contrast Nephropathy
6. Hepatorenal Syndrome
7. Peritoneal Dialysis
8. Continuous Dialysis Treatment of ARF
9. Nutritional Management of ARF
10. Experimental Strategies for ARF-The Future

Part III: Diseases of Glomeruli, Microvasculature, and Tubulointerstitium
11. Renal Biopsy as a Guide to the Treatment of Glomerulonephritis
12. Immunosuppressive Therapy in Immunologic Renal Disease and Transplantation
13. Fish Oils and Other Dietary Treatments of the Inflammatory Response
14. Plasmapheresis
15. Infection-Associated Glomerulonephritis
16. Cryoglobulinemia
17. Lupus Nephritis
18. IgA Nephropathy and Henoch-Schonlein Purpura
19. Rapidly Progressive Glomerulonephritis
20. ANCA-Associated and Other Renal Vasculitides
21. Minimal Change Disease
22. Primary Focal Segmental Glomerulosclerosis
23. Idiopathic Membranous Nephropathy
24. Idiopathic Membranoproliferative Glomerulonephritis
25. Amyloid, Fibrilliary and other Glomerular Deposition Diseases
26. Hepatitis-and HIV-Related Renal Diseases
27. Management of Complications of Nephrotic Syndrome
28. Thrombotic Microangiopathies
29. Acute Interstitial Nephritis
30. New Horizons in the Treatment of Glomerulonephritis
31. Functional genomes: Prospects for New Treatments in Nephrology and Hypertension

Part IV: Diabetic Nephrothy
32. Prevention and Management of Diabetic Nephropathy
33. Management of the Diabetic Patient with Renal Disease

Part V: Disorders of Fluid, Electrolyte, and Acid Based Homeostasis
34. Dysnatremic Disorders
35. Potassium Disorders
36. Metabolic Acidosis
37. Metabolic Alkalosis
38. Hypercalcemia and Other Divalent Cation Disorders

Part VI: Nephrolothiasis
39. Nephrolothiasis
40. Nephrolithiasis: Lithotripsy and Surgery

Part VII: Genitourinary Infections, Malignancy and Obstruction
41. Urinary Tract Infections
42. Primary Neoplasms of the Kidney
43. Myeloma and Secondary Involvement of the Kidney in Neoplastic Diseases
44. Urinary Tract Infections and Obstruction

Part VIII: Renal Disease and Pregnancy
45. Hypertension in Pregnancy
46. Management of Renal Disease in Pregnancy
47. Erectile Dysfunction in ESRD

Part IX: Inherited Renal Disease
48. Renal Cystic Disorders
49. Non-Cystic Hereditary Diseases of the Kidney
50. Prospects for Gene Therapy

Part X: Management of Essential Hypertension
51. Targets and Decisions for Hypertension Treatment
52. Nonpharmacologic Treatment
53. Diuretics and Beta-Blockers
54. ACEIs, ARBs and aldosterone antagonists
55. Calcium Antagonist
56. Individualization of Pharmacologic Therapy
57. Control of CVS Risk Factors in Hypertension
58. Hypertensive urgencies and Emergencies

Part XI: Management of Secondary Hypertension
59. Renovascular Hypertension & Ischemic Nephropathy: Medical Management
60. Renovascular Hypertension & Ischemic Nephropathy: Angioplasty and Stenting
61. Renovascular Hypertension & Ischemic Nephropathy: Surgical Treatment
62. Hypertension in Renal Transplant Recipients
63. Hypertension in Patients Receiving Dialysis Therapy
64. Hypertensive Adrenal Disorders

Part XII: Chronic Renal Failure and Its Systemic Manifestations
65. Prevention of Progressive Renal Failure
66. Dyslipidemia
67. Hyperhomocysteinemia
68. Oxidative Stress
69. Nutritional Therapy
70. Iron and Erythropoietin-Related Therapies
71. Coagulopathy
72. Neuropsychiatric Complications
73. Calcium, Phosphorus and Bone Disease
74. Cardiovascular Complications
75. Erectile Dysfunction

Part XIII: Maintenance Dialysis
76. Technical aspects of Hemodialysis
77. Choice and Maintenance of Vascular Access
78. Hemodialysis Adequacy
79. Complications Associate with Hemodialysis
80. Techniques in Peritoneal Dialysis
81. Complications of Peritoneal Dialysis
82. Peritoneal Dialysis Adequacy
83. Patient Selection for Dialysis and the Decision to Withdraw Treatment

Part XIV: Transplantation
84. Evaluation and Preparation of Donors and Recipients for Renal Transplantation
85. Technical Aspects of Renal Transplantation and Surgical Complications
86. Renal Allograft Dysfunction
87. Noninfectious Complications of Renal Transplantation
88. Infection in the Kidney Transplant Recipient

Part XV: Drugs and the Kidney
89. Drug Dosing in Renal Failure
90. Use of Diuretics of Edema
91. Diuretic Resistance
92. Dialysis and Hemoperfusion in the Treatment of Poisoning And Drug Overdose

Part XVI: Appendix
93. Internet Resources for Nephrologists
Autores
Materias
ISBN
978-0-7216-9681-2
EAN
9780721696812
Editor
Saunders Company
Stock
NO
Idioma
Inglés
Nivel
Profesional
Formato
Encuadernado
Tapa Dura
Páginas
1024
Largo
-
Ancho
-
Peso
1700
Edición
Fecha de edición
01-03-2003
Año de edición
2003
Nº de ediciones
2
Colección
-
Nº de colección
-